Surface Carbon Clad Zirconia as Chiral Stationary Phases

Information

  • Research Project
  • 6402329
  • ApplicationId
    6402329
  • Core Project Number
    R43HL070334
  • Full Project Number
    1R43HL070334-01
  • Serial Number
    70334
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/10/2001 - 23 years ago
  • Project End Date
    3/31/2002 - 22 years ago
  • Program Officer Name
    SWAIN, AMY L
  • Budget Start Date
    9/10/2001 - 23 years ago
  • Budget End Date
    3/31/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/7/2001 - 23 years ago

Surface Carbon Clad Zirconia as Chiral Stationary Phases

DESCRIPTION (provided by applicant): We propose to research and develop means to reproducibly and economically synthesize and use a new class of chiral stationary phases (CSPs) under normal phase conditions based on carbon surfaces. The main goal of this work will be the development a commercially viable reproducible method of synthesizing 3 micron' porous carbon clad-zirconia microsphere derivatized With two Pirkle-typme ligands,namely -(S, S) Whelk-D 1 and about-Burke 1. The key novel approach that we will take is the use of a nonpolar surface, as, the substrate for attaching chiral selectors. This approach to the production of a chiral stationar phase has not been previousl explored and be1ieve that it offers significant advantages over current material's. Once these phases have been developed they will be used to demonstrate'the feasibility of separating several classes of chiral pharmaceuticals including f3-blockers. They will compare separation performance with current state of the art (Pirkie-type) CSPs coupled to silica. We will also test the feasibility of doing chiral separations of basic chiral pharmaceuticals without the presence of special eluent additives, which are currently required. This project will be conducted in close collaboration with Professor Tom Hoye at the University of Minnesota, and Dr. Angelos Kyrlidis at cabot Corporation. PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ZIRCHROM SEPARATIONS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ANOKA
  • Organization State
    MN
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    55303
  • Organization District
    UNITED STATES